|
Minimally invasive image-guided tumor ablation in an oncogenic pig model
|
5R21CA195433-02
|
$266,380
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
|
1R43CA225169-01
|
$295,205
|
SNOOK, KEVIN
|
ACTUATED MEDICAL, INC.
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
1R44CA224460-01
|
$299,805
|
Daunch, William
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types
|
1R43CA213649-01
|
$224,700
|
HOFFMAN, ROBERT
|
ANTICANCER, INC.
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
1R01CA215452-01
|
$362,569
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-01S1
|
$14,309
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
1R03CA215940-01
|
$75,288
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
|
5K99CA212200-02
|
$102,130
|
GUARNERIO, JLENIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
1R01CA214880-01
|
$376,294
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-02
|
$376,294
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-02
|
$380,076
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-18
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-18
|
$2,424,605
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In vivo imaging of single circulating cells
|
5R01CA186567-06
|
$717,674
|
WANG, LIHONG
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
1F31CA213965-01A1
|
$44,044
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
5R21CA209304-02
|
$206,843
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
|
1R21CA218790-01
|
$208,637
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
2P50CA150964-06A1
|
$2,375,000
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
5F30CA186633-04
|
$49,044
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
|
1R03CA219725-01
|
$80,000
|
PETROSIUTE, AGNE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
|
5R01CA193677-02
|
$362,569
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|